drugset / Trial / NCT00390026
The Avastin vs Visudyne for Neovascular AMD Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The object of the study is to compare the treatment effect of bevacizumab (Avastin), an antibody targeting vascular endothelial growth factor, with verteporfin photodynamic therapy (PDT) for patients with neovascular age-related macular degeneration, the leading cause of vision severe loss in the Western world.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Intravitreal |
| Subject | Verteporfin | Other / unclassified | — | — |